Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate

This publication has 15 references indexed in Scilit:

• A comparison of the efficacy and safety of leflunomide and methotrexate for the treatment of rheumatoid arthritis
  Rheumatology, 2000
• Treatment with leflunomide slows radiographic progression of rheumatoid arthritis: Results from three randomized controlled trials of leflunomide in patients with active rheumatoid arthritis
  Arthritis & Rheumatism, 2000
• Clinical improvement as reflected in measures of function and health-related quality of life following treatment with leflunomide compared with methotrexate in patients with rheumatoid arthritis: Sensitivity and relative efficiency to detect a treatment effect in a twelve-month, placebo-controlled trial
  Arthritis & Rheumatism, 2000
• Treatment of Active Rheumatoid Arthritis With Leflunomide Compared With Placebo and Methotrexate
  Archives of internal medicine (1960), 1999
• Function and health-related quality of life: Results from a randomized controlled trial of leflunomide versus methotrexate or placebo in patients with active rheumatoid arthritis
  Arthritis & Rheumatism, 1999
• Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial
  The Lancet, 1999
• Safety and effectiveness of leflunomide in the treatment of patients with active rheumatoid arthritis
  Arthritis & Rheumatism, 1995
• Methotrexate for Rheumatoid Arthritis
  Arthritis & Rheumatism, 1994
• The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis
  Arthritis & Rheumatism, 1988
• Methods of scoring the progression of radiologic changes in rheumatoid arthritis. Correlation of radiologic, clinical and laboratory abnormalities
  Arthritis & Rheumatism, 1971